- Case report
- Open access
- Published:
Watchful waiting for some children with a mediastinal mass: the potential role for 18 F-fluorodeoxyglucose positron emission tomography: a case report and review of the literature
BMC Pediatrics volume 13, Article number: 103 (2013)
Abstract
Background
Benign hyperplastic thymus is a rare but important differential diagnosis of anterior mediastinal lesions. Histological and radiological criteria are used to distinguish this benign condition from other malignant diseases but have their limitations, and biopsy of mediastinal masses can be risky. We report for the first time the diagnostic value of fluorodeoxyglucose 18 F positron emission tomography for patients with incidentally identified anterior mediastinal masses to avoid biopsy in some cases.
Case presentation
A 2 year old girl presented with new onset of emesis and constipation leading to the incidental discovery of an anterior mediastinal mass on radiograph. Chest computed tomography revealed cystic components within the mass concerning for a malignancy. Biopsy of the lesion and bone marrow aspiration and biopsy were negative but there was concern that the mediastinal biopsy may have missed the malignant component of the lesion. Hence, a positron emission tomography scan was obtained that showed mild homogeneous fluorodeoxyglucose 18 F avidity within the mass similar to that of normal thymus. The diagnosis of benign hyperplastic thymus was made.
Conclusion
The differential diagnosis of an incidentally found anterior mediastinal mass includes malignancy, but benign lesions such as benign hyperplastic thymus must also be considered, particularly when the complete blood count and biochemical profile are normal. Fluorodeoxyglucose 18 F positron emission tomography can help guide a clinician’s decision for further interventions and treatment.
Background
Potential etiologies of anterior mediastinal masses in children include benign and malignant tumors whose incidences vary by patient age and symptoms at presentation. Benign hyperplastic thymus (BHT) is a rare condition that occurs mainly in infants and usually resolves spontaneously by 3 years of age, while it seldom occurs in older children and never in adults [1–3]. BHT is characterized by an increase in size of the thymus with normal histological architecture [1–5]. Hence, BHT must be distinguished from follicular hyperplasia in association with Graves’ disease, rebound thymus hyperplasia in cancer patients after chemotherapy, or thymoma and thymolipoma, which do not meet histological criteria for BHT and are mainly seen in adolescents and adults, respectively [1, 6, 7].
Diagnoses such as germ cell tumor, thyroid cancer, and lymphomas (Hodgkin and non-Hodgkin) must be ruled out during diagnostic workup. BHT spontaneously resolves over time, without specific treatment or surveillance; thus, prognosis and management differ from that of malignant etiologies [1, 8]. Fine-needle aspiration cytology and imaging studies (e.g., chest radiograph, ultrasound, and computed tomography [CT]) are used to diagnose BHT in a minimally invasive manner but may result in inadequate biopsy specimens or inconclusive radiologic findings, requiring more invasive and potentially dangerous procedures [9–11]. In one study of 54 children and adults who underwent mediastinal biopsy, the procedure-related morbidity was 6%, and fatalities have been reported [12].
Here we describe a child whose diagnosis of BHT was based on CT-guided core needle biopsy and supported by conventional imaging and 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scan. PET can help differentiate BHT from other conditions associated with an anterior mediastinal mass.
Case presentation
A 2-year-old girl with no significant past medical history was in her usual state of health when she developed non-bloody and non-bilious emesis associated with constipation. A review of other systems was negative. She did not take any medications and family history was non-contributory. In the emergency room, she appeared well and in no acute distress, with a normal physical examination. Weight, height, and vital signs were normal for age and gender. A chest/abdominal radiograph to evaluate her constipation showed no intra-abdominal pathology but demonstrated mediastinal widening (Figure 1A). A CT scan revealed a 10.3 cm × 6.6 cm × 6.3 cm heterogeneous, right-sided anterior mediastinal mass with a single hypodense area likely representing necrosis, and compression of bronchovascular structures. Laboratory tests showed no hematologic or metabolic derangements.
The patient underwent CT-guided core needle biopsy of the lesion, bilateral bone marrow aspirates and biopsies to rule out a malignancy. Hematoxylin and eosin staining and immunohistochemical studies of the mediastinal mass biopsy showed preservation of thymic architecture, with sheets of variably mature small- to intermediate-sized lymphoid cells and few Hassall's corpuscles, consistent with benign thymic tissue. Flow cytometry revealed T-lymphocytes with a full spectrum of orderly thymic maturation patterns, and bone marrow aspirates and biopsies showed normocellular marrow (80%) with trilineage hematopoiesis without evidence of leukemia or lymphoma.
However, the inhomogeneous area within the mass on CT imaging is not a typical finding of BHT and raised concern for a malignancy such as teratoma or lymphoma, which may present with such features (Table 1). PET-CT scan of the large anterior mediastinal mass showedareas of low-intensity, and diffuse, homogeneous FDG avidity, similar to the normal thymus (Figure 1B). Central low-attenuation areas by CT within the mass lacked FDG activity and are suggestive of necrosis (Figure 1C). The standardized uptake value of the lesions ranged from 2.3 to 2.5 MBq/kg, except for the cystic area, which had values less than 2 MBq/kg.
The diagnosis of BHT was made based on histology and lack of FDG avidity on PET scan. The patient continues routine follow up almost a year after original diagnosis with stable mediastinal mass and no further problems or complaints.
Discussion
As the scope of diagnostic imaging broadens, there is greater likelihood of incidental detection of anterior mediastinal masses. Lymphomas and germ cell tumors are the most common malignant tumors of the anterior mediastinum in children; whereas, thymomas seldom occur in this age group [13]. Thymolipomas may occur in young adolescents and adults and occasionally children. Although their radiographic appearance may resemble BHT, thymolipomas present on MRI as mainly fatty masses with inhomogeneous areas that represent thymus tissue [14, 15]. BHT is a rare but important benign condition and must be differentiated from malignant and other benign tumors.
To date, 53 patients with BHT have been reported (Table 2); 34 (64%) of them had respiratory symptoms, and imaging studies revealed a mediastinal mass. In the remaining 19 (36%) patients, the mediastinal lesion was an incidental finding. In either scenario, further diagnostic workup was warranted to rule out a malignancy; however, the implication of malignancy together with imaging findings and parental fear may have led to use of invasive interventions for diagnostic confirmation. Indeed, 79% (15/19) of asymptomatic patients underwent open biopsy and only 26% (9/34) of symptomatic patients were observed clinically without biopsy. In symptomatic patients, open biopsy can be diagnostic and therapeutic, but less invasive procedures are preferred [16].
The primary goal while assessing a mediastinal mass is to rule out oncologic emergencies (anatomic, metabolic, or hematologic) that require immediate medical attention. Workup includes patient’s history, physical examination, routine laboratory tests, and anatomic imaging (Figure 2). After excluding oncologic emergencies, further tests are needed to diagnose the mediastinal lesion.
Physiologic imaging, most often PET-CT, is recommended in the diagnostic process when uncertainty about the malignant versus benign nature of the mass persists (Figure 2) [35].
The pattern and intensity of uptake within such lesions on PET and morphologic appearance on CT can help differentiate benign from malignant etiologies [36] (also see Table 1). To accurately interpret BHT in PET studies, FDG uptake patterns in the normal thymus and pathologic entities involving the thymus need to be known [37]. Normal thymic tissue and benign conditions such as BHT after chemotherapy (so called “thymic rebound”), comparable to our patient, demonstrate diffuse, low-intensity, homogeneous FDG avidity (Table 1) [38, 39].
Malignant conditions show intense FDG avidity that is usually heterogeneous in distribution [40]. The appearance of our patient’s lesion was similar to the normal thymus without focality, suggesting its benign nature (Figure 1B), [41] despite the cystic and necrotic areas within the mass [36, 42]. The morphology and uptake pattern on 18 F-FDG PET are more meaningful than the SUV. There is an overlap in SUV range between normal thymus and other malignant anterior mediastinal tumor entities [43]. Although a very high SUV may be indicative of malignancy, an average SUV does not exclude malignancy [36, 43].
Conclusion
In conclusion, for incidentally found anterior mediastinal masses in otherwise healthy children, we recommend that clinicians expeditiously rule out oncologic emergencies then perform a diagnostic workup. PET scans can help differentiate BHT from other more serious conditions and may spare patients invasive diagnostic procedures.
Further studies including large pediatric series are needed to evaluate the importance of 18 F-fluorodeoxyglucose positron emission tomography in patients with suspected benign hyperplastic thymus.
Consent
Written informed consent was obtained from the patient’s mother for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Abbreviations
- BHT:
-
Benign hyperplastic thymus
- BMA:
-
Bone marrow aspiration
- CT:
-
Computed tomography
- FDG:
-
18 F- fluorodeoxyglucose
- PET:
-
Positron emission tomography
- SUV:
-
Standardized uptake value.
References
Levine GD, Rosai J: Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol. 1978, 9: 495-515. 10.1016/S0046-8177(78)80131-2.
Ricci C, Pescarmona E, Rendina EA, Venuta F, Ruco LP, Baroni CD: True thymic hyperplasia: a clinicopathological study. Ann Thorac Surg. 1989, 47: 741-745. 10.1016/0003-4975(89)90131-8.
Rice HE, Flake AW, Hori T, Galy A, Verhoogen RH: Massive thymic hyperplasia: characterization of a rare mediastinal mass. J Pediatr Surg. 1994, 29: 1561-1564. 10.1016/0022-3468(94)90216-X.
Hofmann WJ, Moller P, Otto HF: Thymic hyperplasia. I. True thymic hyperplasia: review of the literature. Klin Wochenschr. 1987, 65: 49-52. 10.1007/BF01745472.
Ruco LP, Rosati S, Palmieri B, Pescarmona E, Rendina EA, Baroni CD: True thymic hyperplasia: a histological and immunohistochemical study. Histopathol. 1989, 15: 640-643. 10.1111/j.1365-2559.1989.tb01631.x.
Lack EE: Thymic hyperplasia with massive enlargement: report of two cases with review of diagnostic criteria. J Thorac Cardiovasc Surg. 1981, 81: 741-746.
Ballouhey Q, Galinier P, Abbo O, Andrieu G, Baunin C, Sartor A, et al: The surgical management and outcome of congenital mediastinal malformations. Interact Cardiovasc Thorac Surg. 2012, 14: 754-759. 10.1093/icvts/ivs035.
Linegar AG, Odell JA, Fennell WM, Close PM, De Groot MK, Casserly DR, et al: Massive thymic hyperplasia. Ann Thorac Surg. 1993, 55: 1197-1201. 10.1016/0003-4975(93)90033-E.
Bangerter M, Behnisch W, Griesshammer M: Mediastinal masses diagnosed as thymus hyperplasia by fine needle aspiration cytology. Acta Cytol. 2000, 44: 743-747. 10.1159/000328555.
Hoerl HD, Wojtowycz M, Gallagher HA, Kurtycz DF: Cytologic diagnosis of true thymic hyperplasia by combined radiologic imaging and aspiration cytology: a case report including flow cytometric analysis. Diagn Cytopathol. 2000, 23: 417-421. 10.1002/1097-0339(200012)23:6<417::AID-DC12>3.0.CO;2-4.
Parker LA, Gaisie G, Scatliff JH: Computerized tomography and ultrasonographic findings in massive thymic hyperplasia. Case discussion and review of current concepts. Clin Pediatr (Phila). 1985, 24: 90-94. 10.1177/000992288502400206.
Rendina EA, Venuta F, De GT, Ciriaco PP, Pescarmona EO, Francioni F, et al: Comparative merits of thoracoscopy, mediastinoscopy, and mediastinotomy for mediastinal biopsy. Ann Thorac Surg. 1994, 57: 992-995. 10.1016/0003-4975(94)90221-6.
Takeda S, Miyoshi S, Akashi A, Ohta M, Minami M, Okumura M, et al: Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution. J Surg Oncol. 2003, 83: 24-30. 10.1002/jso.10231.
Peters R, Peters O, Braak S, Verschakelen J: Pathology of the thymus on CT-imaging. JBR -BTR. 2012, 95: 281-288.
Rosado-de-Christenson ML, Pugatch RD, Moran CA, Galobardes J: Thymolipoma: analysis of 27 cases. Radiol. 1994, 193: 121-126.
Perger L, Lee EY, Shamberger RC: Management of children and adolescents with a critical airway due to compression by an anterior mediastinal mass. J Pediatr Surg. 2008, 43: 1990-1997. 10.1016/j.jpedsurg.2008.02.083.
Oh KS, Weber AL, Borden S: Normal mediastinal mass in late childhood. Radiol. 1971, 101: 625-628.
O'Shea PA, Pansatiankul B, Farnes P: Giant thymic hyperplasia in infancy: immunologic, histologic, and ultrastructural observations. Lab Invest. 1978, 38: 391-
Barcia PJ, Nelson TG: Hyperplasia of the thymus and thymic neoplasms in children. Mil Med. 1979, 144: 799-801.
Rasore-Quartino A, Rebizzo F, Romagnoli G: [Giant thymus hyperplasia in childhood]. Pathol. 1979, 71: 711-715.
Lamesch AJ: Massive thymic hyperplasia in infants. Z Kinderchir. 1983, 38: 16-18.
Kobayashi T, Hirabayashi Y, Kobayashi Y: Diagnostic value of plain chest roentgenogram and CT scan findings in four cases of massive thymic hyperplasia. Pediatr Radiol. 1986, 16: 452-455. 10.1007/BF02387955.
Nezelof C, Normand C: Tumor-like massive thymic hyperplasia in childhood: a possible defect of T-cell maturation, histological and cytoenzymatic studies of three cases. Thymus. 1986, 8: 177-186.
Judd RL: Massive thymic hyperplasia with myoid cell differentiation. Hum Pathol. 1987, 18: 1180-1183. 10.1016/S0046-8177(87)80388-X.
Lee YM, Koh MT, Omar A, Majid A: Hyperplasia of thymic gland. Singapore Med J. 1996, 37: 288-290.
Tareen FK, Hussain S, Moazam F: Thymic hyperplasia: a cause of respiratory distress. J Pak Med Assoc. 2001, 51: 300-302.
Sosothikul D, Nuchprayoon I, Mahayosnond A, Wannakrairot P, Seksarn P: Massive thymic hyperplasia mimicking lymphoma: a case report and review of the literature. Thai J Hematol Transf Med. 2002, 12: 301-307.
Gow KW, Kobrynski L, Abramowsky C, Lloyd D: Massive benign thymic hyperplasia in a six-month-old girl: case report. Am Surg. 2003, 69: 717-719.
Piednoir P, Taylor G, Gayat E, Devys JM: Benign thymic hyperplasia: an unexpected cause of respiratory distress during inhalatory induction of anesthesia. Paediatr Anaesth. 2008, 18: 1220-1221. 10.1111/j.1460-9592.2008.02707.x.
Szarf G, de Andrade TC, de Oliveira R, Ota LH, Lederman HM: Massive thymic hyperplasia presenting with respiratory insufficiency in a 2-year-old child. Thorax. 2010, 65: 555-556. 10.1136/thx.2009.123125.
Tan Z, Ying LY, Zhang ZW, Li JH, Gao Z, Qi JC: True thymic hyperplasia in an infant. J Pediatr Surg. 2010, 45: 1711-1713. 10.1016/j.jpedsurg.2010.05.001.
Katz SM, Chatten J, Bishop HC, Rosenblum H: Report of a case of gross thymic hyperplasia in a child. Am J Clin Pathol. 1977, 68: 786-790.
Lee Y, Moallem S, Clauss RH: Massive hyperplastic thymus in a 22-month-old infant. Ann Thorac Surg. 1979, 27: 356-358. 10.1016/S0003-4975(10)63315-2.
Arliss J, Scholes J, Dickson PR, Messina JJ: Massive thymic hyperplasia in an adolescent. Ann Thorac Surg. 1988, 45: 220-222. 10.1016/S0003-4975(10)62443-5.
Jr. Ray CE, English B, Funaki BS, Burke CT, Fidelman N, Ginsburg ME, et al: ACR appropriateness criteria(R) radiologic management of thoracic nodules and masses. J Am Coll Radiol. 2012, 9: 13-19. 10.1016/j.jacr.2011.09.013.
Ferdinand B, Gupta P, Kramer EL: Spectrum of thymic uptake at 18F-FDG PET. Radiographics. 2004, 24: 1611-1616. 10.1148/rg.246045701.
Shammas A, Lim R, Charron M: Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions. Radiographics. 2009, 29: 1467-1486. 10.1148/rg.295085247.
Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G, Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G: Normal thymic uptake of FDG on PET imaging. Clin Nucl Med. 1996, 21: 772-775. 10.1097/00003072-199610000-00004.
Wittram C, Fischman AJ, Mark E, Ko J, Shepard JA: Thymic enlargement and FDG uptake in three patients: CT and FDG positron emission tomography correlated with pathology. AJR Am J Roentgenol. 2003, 180: 519-522. 10.2214/ajr.180.2.1800519.
Kubota K, Yamada S, Kondo T, Yamada K, Fukuda H, Fujiwara T, et al: PET imaging of primary mediastinal tumours. Br J Cancer. 1996, 73: 882-886. 10.1038/bjc.1996.157.
Gawande RS, Khurana A, Messing S, Zhang D, Castaneda RT, Goldsby RE, et al: Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiol. 2012, 262: 613-622. 10.1148/radiol.11110715.
Babagbemi K, Hunsaker AR: Nonvascular lesions of the mediastinum [review]. Applied Radiology. 2002, 31 (5): 33-41.
Sasaki M, Kuwabara Y, Ichiya Y, Akashi Y, Yoshida T, Nakagawa M, et al: Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. J Nucl Med. 1999, 40: 1595-1601.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/13/103/prepub
Acknowledgments
This research study is supported by the National Institutes of Health Cancer Support Core Grant (CA-21765 to MLM) and the American Lebanese Syrian Associated Charities (ALSAC to JLC and MLM).
We thank Vani Shankar from St Jude for final editorial assistance as it relates to grammar and style.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors have participated in study design, interpretation, and writing of the report. RN did the collection of the data, review of literature, and drafted the first version of the manuscript. JLC provided the figures and reviewed the manuscript. SCH reviewed the manuscript. MLM primarily participated in study design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Nguyen, R., Coleman, J.L., Howard, S.C. et al. Watchful waiting for some children with a mediastinal mass: the potential role for 18 F-fluorodeoxyglucose positron emission tomography: a case report and review of the literature. BMC Pediatr 13, 103 (2013). https://doi.org/10.1186/1471-2431-13-103
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1471-2431-13-103